• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • RXi and Karolinska Institutet target solid tumour therapy pharmaceutical-technology
    August 17, 2018
    US-based biotechnology company RXi Pharmaceuticals has formed a research alliance with the Karolinska Institutet in Stockholm, Sweden, to develop and improve immuno-oncology treatments for solid tumours.
  • Developing nanopreparation properties for use in anticancer medicines europeanpharmaceuticalreview
    March 16, 2017
    Tumour therapy, particularly in the case of multidrug resistant cancers, could be significantly enhanced by using siRNA to down-regulate the production of proteins involved in cancer cell resistance such as Pgp or survivin...

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service